UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000054614
Receipt number R000062401
Scientific Title A comparative study of the discontinuation rate of Intravenous patient-controlled analgesia used after posterior spinal fusion surgery with intraoperative ondansetron administration. A
Date of disclosure of the study information 2024/06/10
Last modified on 2024/06/09 17:07:39

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A comparative study of the discontinuation rate of Intravenous patient-controlled analgesia used after posterior spinal fusion surgery with intraoperative ondansetron administration. 1

Acronym

A comparative study of the discontinuation rate of Intravenous patient-controlled analgesia used after posterior spinal fusion surgery with intraoperative ondansetron administration.

Scientific Title

A comparative study of the discontinuation rate of Intravenous patient-controlled analgesia used after posterior spinal fusion surgery with intraoperative ondansetron administration. A

Scientific Title:Acronym

A comparative study of the discontinuation rate of Intravenous patient-controlled analgesia used after posterior spinal fusion surgery with intraoperative ondansetron administration. B

Region

Japan


Condition

Condition

posterior spinal fusion surgery

Classification by specialty

Anesthesiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The purpose of this study is to compare whether intraoperative administration of ondansetron affects the discontinuation rate of transvenous patient-controlled analgesia after posterior spinal fusion surgery.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

the discontinuation rate of transvenous patient-controlled analgesia

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Single blind -participants are blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Anesthesia is administered by inhalation with sevoflurane and remifentanil. Fentanyl 9 mcg/kg and acetaminophen 15 mg/kg are administered as intraoperative analgesics. Transvenous patient-controlled analgesia is used for a total of 60 ml of fentanyl, saline, and 5 mg of droperidol to achieve 0.5 mcg/kg/h of fentanyl when used at 2 ml/h. During surgery, 4 mg of ondansetron and 1.25 mg of droperidol are administered.

Interventions/Control_2

Anesthesia is administered by inhalation with sevoflurane and remifentanil. Fentanyl 9 mcg/kg and acetaminophen 15 mg/kg are administered as intraoperative analgesics. Transvenous patient-controlled analgesia is used for a total of 60 ml of fentanyl, saline, and 5 mg of droperidol to achieve 0.5 mcg/kg/h of fentanyl when used at 2 ml/h. During surgery, 1.25 mg of droperidol are administered.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

ASA-1 or 2 phyisical status patients undergoing posterior spinal fusion between 1 or 2 vertebrae from the date of approval by the Ethics Review Committee in 2024 and the date of the Institutional Director's approval until March 31, 2025.

Key exclusion criteria

1. Asthma 2. Long QT syndrome 3. Patients who did not give consent

Target sample size

50


Research contact person

Name of lead principal investigator

1st name Soejima
Middle name
Last name Yuki

Organization

Nagasaki rosai hospitsl

Division name

Anesthesiology

Zip code

857-0134

Address

2-12-5 Setogoe, Sasebo ciity, Nagasaki

TEL

0956-49-2191

Email

shomu@nagasaki.johas.go.jp


Public contact

Name of contact person

1st name Soejima
Middle name
Last name Yuki

Organization

Nagasaki rosai hospital

Division name

Anesthesiology

Zip code

8570134

Address

2-12-5 Setogoe, Sasebo ciity, Nagasaki

TEL

09020869792

Homepage URL


Email

yukisoejima08@gmail.com


Sponsor or person

Institute

Nagasaki rosai hospital, Anesthesiology, Yuki Soejima

Institute

Department

Personal name

Yuki Soejima


Funding Source

Organization

Nagasaki rosai hospital

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Nagasaki rosai hospital

Address

2-12-5 Setogoe, Sasebo ciity, Nagasaki

Tel

0956492191

Email

shomu@nagasaki.johas.go.jp


Secondary IDs

Secondary IDs

YES

Study ID_1

0513

Org. issuing International ID_1

Nagasaki rosai hospital

Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2024 Year 06 Month 10 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2024 Year 03 Month 18 Day

Date of IRB

2024 Year 03 Month 18 Day

Anticipated trial start date

2024 Year 04 Month 01 Day

Last follow-up date

2025 Year 04 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2024 Year 06 Month 09 Day

Last modified on

2024 Year 06 Month 09 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000062401